Global Medical Director, Multiple Myeloma

Role Summary

The Global Medical Director in Multiple Myeloma is a unique opportunity for an experienced, innovative, and proactive medical professional to facilitate the understanding of the value of our medicines, the science behind them and the public impact they can offer. This is accomplished by developing and implementing the global medical scientific strategic plan to generate insights, shape optimal care through scientific dialogue and education and delivering impact by generating and communicating the evidence and delivering solutions to close the gaps. The Global Medical Director for Multiple Myeloma will work in a thriving team of medical business leaders where people will be inspired to drive towards achieving our goals of getting Ahead of Disease Together and positively impacting patient and population health outcomes globally to help close gaps in medical care.

Responsibilities

• Plays an integral role in building/optimizing the Global Medical Affairs Plan (MAP) and Integrated Evidence Plan (IEP) for the relevant asset/indication(s).
• Drives delivery of designated above-country elements of the MAP, e.g., Advisory Boards, Symposia, Educational Events.
• Partners with commercial colleagues to optimize brand strategy, campaigns and launches in the Franchise Local Operating Companies (LOCs).
• Leading and overseeing partnerships from a GMA perspective for the relevant asset/indication(s).
• Drives the development and/or approval of promotional, educational, training and other materials and responses.
• Drives the congress planning and coordination from a brand perspective, including pre- and post-congress deliverables.
• Drives the scientific training coordination and execution from a brand perspective, including material development and/or approval.
• Delivers the evidence needs for that asset on behalf of the GMAL.
• Drives the efficient working of the Integrated Evidence Team; ensuring insights from Franchise LOCs are integrated appropriately to inform the IEP.
• Reviews local GSK-sponsored and Investigator Sponsored Study (ISS) proposals from Franchise LOCs to assess their scientific merit and strategic need, liaising with R&D experts.
• Accountable for the development of assigned Franchise study protocols.
• Accountable for developing the strategy and critically assessing the post hoc analysis plan, outputs and strategy.
• Drives excellence in Scientific Engagement (SE) with key stakeholders (HCPs, Patients, Payors and Regulators) to gain a deep understanding of customer needs.
• Deputizes regularly for the GMAL as required.

Qualifications

• Required: 5+ years of Medical Affairs including roles in LOCs and supporting pre/peri launch phases of assets in the oncology / haematology space.
• Required: Robust experience leading post hoc analysis planning and execution.
• Required: Competency with promotional codes/regulations; previous involvement in review and approval processes.
• Required: Demonstrated experience leading external engagement strategy at the local or global level.
• Required: Ability to work across time zones and to travel internationally (25%- 50%).
• Required: Must possess strong interpersonal, verbal, and written communication skills in English.

• Preferred: Previous clinical or scientific experience in Multiple Myeloma and hematology.
• Preferred: Robust understanding of internal and external codes of practice and regulations (certification where applicable).
• Preferred: Experience in medical support for briefing documents for regulatory interactions and payor dossiers.
• Preferred: Demonstrated experience with developing global or local medical strategies and asset launches, especially within a priority market.
• Preferred: Skilled at simultaneous consideration of scientific data and practical healthcare delivery needs from diverse health systems to optimize medical implementation of innovation.